Xcell Therapeutics Passes KOSDAQ Technology Evaluation

Xcell Therapeutics passes KOSDAQ technology evaluation…claims preliminary listing in September 

“Entering the global market in earnest after listing on KOSDAQ” 

Xcell Therapeutics, a company specializing in culture media for cell and gene therapy (CGT), announced today that it has passed the technology assessment for a special listing on KOSDAQ.

Link